v3.26.3
Condensed Consolidated Statements of Shareholders’ Equity (Unaudited) - USD ($)
shares in Millions, $ in Millions
Total
Ordinary Shares and Additional Paid-in Capital
Accumulated Deficit
Accumulated  Other Comprehensive Loss, Net of Tax
Non- redeemable Non- controlling Interests
Beginning balance (in shares) at Dec. 31, 2024   216.0      
Beginning balance at Dec. 31, 2024 $ 6,305 $ 13,175 $ (2,309) $ (4,745) $ 184
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income [1] 986   965   21
Shares issued - employee stock compensation plans (in shares)   0.7      
Shares issued - employee stock compensation plans (111) $ (111)      
Shares repurchased (in shares)   (0.6)      
Shares repurchased (250)   (250)    
Share-based compensation expense 147 $ 147      
Dividends to shareholders (146)   (146)    
Net change in fair value of financial instruments 3     3  
Net foreign currency translation adjustments 239     239  
Net postretirement benefit obligation 47     47  
Dividends paid to nonredeemable noncontrolling interests on subsidiary common stock (14)       (14)
Remeasurement of redemption value of redeemable noncontrolling interest (11) $ (11)      
Ending balance (in shares) at Mar. 31, 2025   216.1      
Ending balance at Mar. 31, 2025 $ 7,195 $ 13,200 (1,740) (4,456) 191
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common Stock, Dividends, Per Share, Cash Paid $ 0.675        
Beginning balance (in shares) at Dec. 31, 2024   216.0      
Beginning balance at Dec. 31, 2024 $ 6,305 $ 13,175 (2,309) (4,745) 184
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net change in fair value of financial instruments 4        
Net foreign currency translation adjustments 752        
Net postretirement benefit obligation 74        
Ending balance (in shares) at Sep. 30, 2025   215.2      
Ending balance at Sep. 30, 2025 8,114 $ 13,381 (1,527) (3,915) 175
Beginning balance (in shares) at Mar. 31, 2025   216.1      
Beginning balance at Mar. 31, 2025 7,195 $ 13,200 (1,740) (4,456) 191
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income [2] 593   579   14
Shares issued - employee stock compensation plans (in shares)   0.3      
Shares issued - employee stock compensation plans (50) $ (49) (1)    
Shares repurchased (in shares)   (0.7)      
Shares repurchased (250)   (250)    
Share-based compensation expense 119 $ 119      
Dividends to shareholders (162)   (162)    
Net change in fair value of financial instruments 10     10  
Net foreign currency translation adjustments 604     604  
Net postretirement benefit obligation (1)     (1)  
Purchases of subsidiary shares from noncontrolling interests (9) (9)      
Dividends paid to nonredeemable noncontrolling interests on subsidiary common stock (40)       (40)
Remeasurement of redemption value of redeemable noncontrolling interest (1) $ (1)      
Ending balance (in shares) at Jun. 30, 2025   215.7      
Ending balance at Jun. 30, 2025 $ 8,008 $ 13,260 (1,574) (3,843) 165
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common Stock, Dividends, Per Share, Cash Paid $ 0.745        
Net income [3] $ 470   458   12
Shares issued - employee stock compensation plans (in shares)   0.2      
Shares issued - employee stock compensation plans 20 $ 20      
Shares repurchased (in shares)   (0.7)      
Shares repurchased (250)   (250)    
Share-based compensation expense 106 $ 106      
Dividends to shareholders (161)   (161)    
Net change in fair value of financial instruments (9)     (9)  
Net foreign currency translation adjustments (91)     (91)  
Net postretirement benefit obligation 28     28  
Purchases of subsidiary shares from noncontrolling interests (1) (1)      
Dividends paid to nonredeemable noncontrolling interests on subsidiary common stock (2)       (2)
Remeasurement of redemption value of redeemable noncontrolling interest (4) $ (4)      
Ending balance (in shares) at Sep. 30, 2025   215.2      
Ending balance at Sep. 30, 2025 $ 8,114 $ 13,381 (1,527) (3,915) 175
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common Stock, Dividends, Per Share, Cash Paid $ 0.745        
Beginning balance (in shares) at Dec. 31, 2025 214.5 214.5      
Beginning balance at Dec. 31, 2025 $ 9,459 $ 13,440 (245) (3,843) 107
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income [4] 1,240   1,212   28
Shares issued - employee stock compensation plans (in shares)   0.6      
Shares issued - employee stock compensation plans (68) $ (68)      
Shares repurchased (in shares)   (1.5)      
Shares repurchased (500)   (500)    
Share-based compensation expense 82 $ 82      
Dividends to shareholders (160)   (160)    
Net change in fair value of financial instruments (4)     (4)  
Net foreign currency translation adjustments (108)     (108)  
Net postretirement benefit obligation 27     27  
Purchases of subsidiary shares from noncontrolling interests (3) (2)     (1)
Dividends paid to nonredeemable noncontrolling interests on subsidiary common stock (10)       (10)
Remeasurement of redemption value of redeemable noncontrolling interest 3 $ 3      
Ending balance (in shares) at Mar. 31, 2026   213.6      
Ending balance at Mar. 31, 2026 $ 9,958 $ 13,455 307 (3,928) 124
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common Stock, Dividends, Per Share, Cash Paid $ 0.745        
Beginning balance (in shares) at Dec. 31, 2025 214.5 214.5      
Beginning balance at Dec. 31, 2025 $ 9,459 $ 13,440 (245) (3,843) 107
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net change in fair value of financial instruments 17        
Net foreign currency translation adjustments (157)        
Net postretirement benefit obligation $ 78        
Ending balance (in shares) at Sep. 30, 2026 212.2 212.2      
Ending balance at Sep. 30, 2026 $ 10,197 $ 13,622 384 (3,905) 96
Beginning balance (in shares) at Mar. 31, 2026   213.6      
Beginning balance at Mar. 31, 2026 9,958 $ 13,455 307 (3,928) 124
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income [5] 565   551   14
Shares issued - employee stock compensation plans (in shares)   0.3      
Shares issued - employee stock compensation plans (46) $ (46)      
Shares repurchased (in shares)   (1.9)      
Shares repurchased (600)   (600)    
Share-based compensation expense 122 $ 122      
Dividends to shareholders (176)   (176)    
Net change in fair value of financial instruments (5)     (5)  
Net foreign currency translation adjustments (78)     (78)  
Net postretirement benefit obligation 25     25  
Purchases of subsidiary shares from noncontrolling interests (36) (27)     (9)
Dividends paid to nonredeemable noncontrolling interests on subsidiary common stock (41)       (41)
Remeasurement of redemption value of redeemable noncontrolling interest (2) $ (2)      
Ending balance (in shares) at Jun. 30, 2026   212.0      
Ending balance at Jun. 30, 2026 $ 9,686 $ 13,502 82 (3,986) 88
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common Stock, Dividends, Per Share, Cash Paid $ 0.820        
Net income [6] $ 486   476   10
Shares issued - employee stock compensation plans (in shares)   0.2      
Shares issued - employee stock compensation plans 12 $ 12      
Share-based compensation expense 104 104      
Dividends to shareholders (174)   (174)    
Net change in fair value of financial instruments 26     26  
Net foreign currency translation adjustments 29     29  
Net postretirement benefit obligation 26     26  
Dividends paid to nonredeemable noncontrolling interests on subsidiary common stock (2)       (2)
Remeasurement of redemption value of redeemable noncontrolling interest $ 4 $ 4      
Ending balance (in shares) at Sep. 30, 2026 212.2 212.2      
Ending balance at Sep. 30, 2026 $ 10,197 $ 13,622 $ 384 $ (3,905) $ 96
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common Stock, Dividends, Per Share, Cash Paid $ 0.820        
[1] The Company’s Net income totaled $982 million for the quarter ended March 31, 2025, which included $4 million of Net loss related to redeemable noncontrolling interests.
[2] The Company’s Net income totaled $594 million for the quarter ended June 30, 2025, which included $1 million of Net income related to redeemable noncontrolling interests.
[3] The Company’s Net income totaled $470 million for the quarter ended September 30, 2025, which included an insignificant amount of Net income related to redeemable noncontrolling interests.
[4] The Company’s Net income totaled $1.2 billion for the quarter ended March 31, 2026, which included $1 million of Net loss related to redeemable noncontrolling interests.
[5] The Company’s Net income totaled $565 million for the quarter ended June 30, 2026, which included an insignificant Net loss related to redeemable noncontrolling interests.
[6] The Company’s Net income totaled $486 million for the quarter ended September 30, 2026, which included an insignificant Net loss related to redeemable noncontrolling interests.